第一作者机构：[1]Guangdong Med Univ, Affiliated Longhua Cent Hosp, Dept Gen Med, Shenzhen, Peoples R China
通讯作者：
通讯机构：[6]Guangdong Med Univ, Affiliated Longhua Cent Hosp, Dept Endocrinol, Shenzhen, Peoples R China
推荐引用方式(GB/T 7714)：
Qiu Mei,Liu Shu-Yan,Gu Jin-Song,et al.Do reductions in risk of cardiorenal events with SGLT2 inhibitors in type 2 diabetes vary with baseline characteristics? A meta-analysis[J].ENDOCRINE.2020,69(3):688-691.doi:10.1007/s12020-020-02359-5.
APA：
Qiu, Mei,Liu, Shu-Yan,Gu, Jin-Song,Li, Kai-Kai,Li, Ling-Lin&Ding, Liang-Liang.(2020).Do reductions in risk of cardiorenal events with SGLT2 inhibitors in type 2 diabetes vary with baseline characteristics? A meta-analysis.ENDOCRINE,69,(3)
MLA：
Qiu, Mei,et al."Do reductions in risk of cardiorenal events with SGLT2 inhibitors in type 2 diabetes vary with baseline characteristics? A meta-analysis".ENDOCRINE 69..3(2020):688-691
